{
  "id": 12850224,
  "title": "Argenx's study flop in Sjögren's overshadows a win in celiac disease",
  "url": "https://urgent.news/2026/10/08/argenxs-study-flop-in-sjogrens-overshadows-a-win-in-celiac-disease",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-08T11:00:06.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/argenxs-study-flop-in-sjogrens-overshadows-a-win-in-celiac-disease/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Argenx on Thursday reported one success and one setback in its autoimmune disease pipeline, sending its shares tumbling. The Belgian-Dutch pharma said it is shuttering a Phase 3 trial of its ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}